Features of PMN Senescence that Lead to Susceptibility to Pneumococcal Infection

导致肺炎球菌感染易感性的中性粒细胞衰老特征

基本信息

  • 批准号:
    10356895
  • 负责人:
  • 金额:
    $ 21.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT/SUMMARY Immunosenescence, the age-related decline in immune function, is manifested by an increase in susceptibility to many infectious diseases, including serious Streptococcus pneumoniae (pneumococcus) infection. Acute pulmonary inflammation is characteristic of pneumococcal lung infection and may exacerbate tissue damage and disease progression. The elderly suffer from `Inflammaging', the age-dependent increase in basal and induced levels of proinflammatory cytokines. Further, polymorphonuclear leukocytes (PMNs) from elderly individuals display defects in several activities, such as chemotaxis, opsonophagocytic killing, and ROS production. Using a model of intratracheal challenge of wild-type mice, which recapitulates the susceptibility to pneumococcal infection among the elderly, our preliminary data suggests that PMN dysfunction may be a primary cause of the increased susceptibility to pneumococcal pneumonia. Furthermore, adoptive transfer of PMNs from young mice into aged mice conferred resistance to pneumococcal lung challenge, indicating that young PMNs possess defense functions that are lacking in aged PMNs. Comparing the gene expression of uninfected or pneumococcus-exposed PMNs from young and aged mice (by our collaborator Dr. Bou Ghanem) revealed age-dependent expression differences. However, the precise PMN dysfunction leading to age- dependent susceptibility remains unknown and is a focus of this proposal. Here we propose to identify the specific PMN functions that diminish with age and result in the susceptibility to pneumococcal lung infection, as well as systematically test the degree to which age-associated, PMN-mediated susceptibility is due to a diminished defense and/or an enhanced disease-promoting activity. By pinpointing the key host defenses that degrade with age and result in invasive pneumococcal disease, these studies will not only facilitate precisely targeted interventions against a major infectious agent, but also provide insight into the aging innate immune system that may lead to novel therapies against other infections that disproportionately afflict the elderly. In addition, taking a high-risk, high-reward approach, we seek to treat PMNs derived from HoxB8 progenitor cell lines with low levels of inflammatory cytokines found in the bloodstream of the aged host to confer on these PMNs an aged phenotypic profile with respect to PMN activities and RNA expression. Our Aims are (1) Characterize PMN functions that diminish upon aging and recapitulation these defects in PMNs derived from immortalized myeloid progenitors. (2) Assess the degree to which aged PMNs not only fail to defend against infection but also actively promote pneumococcal disease, thus contributing to age-associated susceptibility to S. pneumoniae.
项目摘要/摘要 免疫衰老是与年龄相关的免疫功能下降,表现为易感性的增加。 对多种传染病,包括严重的肺炎链球菌(肺炎球菌)感染。急性 肺部炎症是肺炎球菌肺部感染的特征,可能会加剧组织损伤。 和疾病的进展。老年人患有‘炎症性’,与年龄相关的基础和 诱导促炎细胞因子水平。此外,老年人的中性粒细胞(PMN) 个体在几种活动中表现出缺陷,如趋化、吞噬细胞杀伤和ROS 制作。使用野生型小鼠的气管内攻击模型,概括了对 肺炎球菌在老年人中的感染,我们的初步数据表明PMN功能障碍可能是 肺炎球菌肺炎易感性增加的主要原因。此外,收养转让 从年轻小鼠到老年小鼠的PMN对肺炎球菌肺攻击具有抵抗力,表明 年轻的中性粒细胞具有老年中性粒细胞所缺乏的防御功能。比较两种病毒的基因表达 来自幼鼠和老年鼠的未感染或肺炎球菌暴露的PMN(由我们的合作者Bou Garem博士提供) 揭示了年龄相关的表达差异。然而,导致衰老的确切的PMN功能障碍- 依赖易感性仍不清楚,这是这项提议的一个重点。在这里,我们建议确定 中性粒细胞的特定功能随着年龄的增长而减弱,并导致对肺炎球菌肺部感染的易感性,如 以及系统地测试与年龄相关的PMN介导的易感性是由于 抵抗力减弱和/或促进疾病的活动增强。通过精确定位关键的主机防御, 随着年龄的增长而退化并导致侵袭性肺炎球菌疾病,这些研究不仅将有助于准确地 针对主要感染源的有针对性的干预,也提供了对老化的先天免疫的洞察 这一系统可能导致针对其他感染的新疗法,这些感染对老年人造成了不成比例的痛苦。在……里面 此外,采用高风险、高回报的方法,我们寻求治疗来自HoxB8祖细胞的PMN 在老年宿主的血液中发现的炎性细胞因子水平较低的品系与这些 中性粒细胞是一种关于中性粒细胞活性和RNA表达的衰老表型.我们的目标是(1) 描述PMN功能随年龄增长而减弱的特征,并概括PMN的这些缺陷 永生的髓系祖细胞。(2)评估老化的PMN不仅没有防御到什么程度 感染还会积极促进肺炎球菌病,从而导致与年龄相关的易感性 肺炎链球菌。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neutrophils require SKAP2 for reactive oxygen species production following C-type lectin and Candida stimulation.
  • DOI:
    10.1016/j.isci.2021.102871
  • 发表时间:
    2021-08-20
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Nguyen GT;Xu S;Adams W;Leong JM;Bunnell SC;Mansour MK;Sykes DB;Mecsas J
  • 通讯作者:
    Mecsas J
The Yin and Yang of Pneumolysin During Pneumococcal Infection.
  • DOI:
    10.3389/fimmu.2022.878244
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M LEONG其他文献

JOHN M LEONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M LEONG', 18)}}的其他基金

Features of PMN Senescence that Lead to Susceptibility to Pneumococcal Infection
导致肺炎球菌感染易感性的中性粒细胞衰老特征
  • 批准号:
    10152199
  • 财政年份:
    2021
  • 资助金额:
    $ 21.38万
  • 项目类别:
Effect of Shiga toxin, OMVs, and innate immune cells on epithelial integrity of human colonoids during EHEC infection
志贺毒素、OMV 和先天免疫细胞对肠出血性大肠杆菌感染期间人结肠上皮完整性的影响
  • 批准号:
    10112822
  • 财政年份:
    2020
  • 资助金额:
    $ 21.38万
  • 项目类别:
Effect of Shiga toxin, OMVs, and innate immune cells on epithelial integrity of human colonoids during EHEC infection
志贺毒素、OMV 和先天免疫细胞对肠出血性大肠杆菌感染期间人结肠上皮完整性的影响
  • 批准号:
    9978339
  • 财政年份:
    2020
  • 资助金额:
    $ 21.38万
  • 项目类别:
FASEB SRC on Molecular Pathogenesis: Mechanisms of Infectious Disease
FASEB SRC 关于分子发病机制:传染病机制
  • 批准号:
    8908265
  • 财政年份:
    2015
  • 资助金额:
    $ 21.38万
  • 项目类别:
CRASP-mediated Serum Resistance by Borrelia burgdorferi
CRASP 介导的伯氏疏螺旋体的血清耐药性
  • 批准号:
    8953318
  • 财政年份:
    2015
  • 资助金额:
    $ 21.38万
  • 项目类别:
CRASP-mediated Serum Resistance by Borrelia burgdorferi
CRASP 介导的伯氏疏螺旋体的血清耐药性
  • 批准号:
    9087098
  • 财政年份:
    2015
  • 资助金额:
    $ 21.38万
  • 项目类别:
Stx-mediated disease and immunomodulatory effectors of enterohemorrhagic E.coli
Stx介导的肠出血性大肠杆菌疾病和免疫调节效应器
  • 批准号:
    8570980
  • 财政年份:
    2013
  • 资助金额:
    $ 21.38万
  • 项目类别:
Stx-mediated disease and immunomodulatory effectors of enterohemorrhagic E.coli
Stx介导的肠出血性大肠杆菌疾病和免疫调节效应器
  • 批准号:
    8692645
  • 财政年份:
    2013
  • 资助金额:
    $ 21.38万
  • 项目类别:
EHEC-induced actin rearrangement and Stx2 translocation across epithelium
EHEC 诱导的肌动蛋白重排和 Stx2 跨上皮易位
  • 批准号:
    8207883
  • 财政年份:
    2011
  • 资助金额:
    $ 21.38万
  • 项目类别:
EHEC-induced actin rearrangement and Stx2 translocation across epithelium
EHEC 诱导的肌动蛋白重排和 Stx2 跨上皮易位
  • 批准号:
    8029721
  • 财政年份:
    2011
  • 资助金额:
    $ 21.38万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 21.38万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 21.38万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 21.38万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 21.38万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 21.38万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 21.38万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 21.38万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 21.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了